This post outlines practical steps Congress should take to strengthen pharmaceutical border security, reinforce regulatory oversight, and protect patients.
A patient at a North Dakota med spa told investigators she had to coach the clinic owner through the IV administration process. The owner allegedly presented herself as a registered nurse, despite holding no medical licenses.
The bill will protect Iowa’s patients by closing enormous regulatory gaps in the med spa and wellness industry.
The agency has found websites and social media advertisements displaying official Health Canada logos with fake endorsements to mislead consumers, and said that it doesn’t endorse health products or permit its logo to be used in ads that promote them.
Reporting on PSM-led research led Google to suppress pill press ads, Congressman Raja Krishnamoorthi sent letters to shippers of weight loss drugs and API, and a former nurse was charged with distributing counterfeit Ozempic.
As of the first week of January, we found several companies with multiple ads still running well past its self-imposed deadline. Google can do better, but will they?
The FDA has posted notices for two nationwide dietary supplement recalls involving products found to contain undeclared pharmaceutical ingredients.
New York found widespread safety violations in med spas, and FDA inspectors cited a Texas distributor for violating the DSCSA.
Our analysis of data in September and October 2025 revealed that large-scale freight fraud involving GLP-1s, oncology drugs, and other high-demand pharmaceuticals continues unabated.
CBP reported seizing 450 shipments of illegally imported contact lenses and prescription medicines. Dozens of state AGs asked Meta to enforce policies against misleading weight loss products.